Results 71 to 80 of about 1,252,143 (218)

Infrared laser pulse triggers increased singlet oxygen production in tumour cells [PDF]

, 2013
Photodynamic therapy (PDT) is a technique developed to treat the ever-increasing global incidence of cancer. This technique utilises singlet oxygen (1O2) generation via a laser excited photosensitiser (PS) to kill cancer cells.
Goltsov, Alexey, Pourreyron, C., Rafailov, E. U., Sokolovski, S. G., South, A. P., Zolotovskaya, S. A.   +5 more
core   +4 more sources

Non-viral delivery and optimized optogenetic stimulation of retinal ganglion cells led to behavioral restoration of vision [PDF]

, 2012
Stimulation of retinal neurons using optogenetics via use of chanelrhodopsin-2 (ChR2) has opened up a new direction for restoration of vision for treatment of retinitis pigmentosa (RP).
Edward Wong, Ling Gu, Mathew Ficinski, Samarendra Mohanty, Samarendra Mohanty, Shivaranjani Shivalingaiah   +5 more
core   +2 more sources

810-nm Photobiomodulation Evokes Glutamate Release in Normal and Rotenone-Dysfunctional Cortical Nerve Terminals by Modulating Mitochondrial Energy Metabolism

Cells
The dysfunction of mitochondria, the primary source of cellular energy and producer of reactive oxygen species (ROS), is associated with brain aging and neurodegenerative diseases. Scientific evidence indicates that light in the visible and near-infrared
Silvia Ravera, Elisa Farsetti, Guido Maura, Manuela Marcoli, Matteo Bozzo, Chiara Cervetto, Andrea Amaroli   +6 more
doaj   +1 more source

Treatment of head and neck cancer with photodynamic therapy: results after one year [PDF]

, 2007
Photodynamic therapy (PDT) is a new and promising treatment modality for the treatment of malignant disease. This paper reports the preliminary experience of our group in the use of this therapy for the treatment of tumours arising in the head and neck ...
DeJode, ML, Dilkes, MG, Gardiner, Q, Kenyon, GS, McKelvie, P   +4 more
core   +1 more source

A Systematic Review: Light Therapy for Individuals with Dementia and Implications for Practice [PDF]

, 2019
This systematic review seeks to answer the question: is light therapy an effective intervention for sundowning symptoms experienced by individuals who have ...
Goodman, OTS, E., Jacobs, MS, OTS, E., Kaiser, OTD, OTR/L, L., Mikus, OTS, C., Milione, OTS, A., Potvin, PhD, OTR/L, M.-C., Torres, OTS, A., Vu, OTS, V.   +7 more
core   +1 more source

Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus. [PDF]

, 2013
Usher 1 patients are born profoundly deaf and then develop retinal degeneration. Thus they are readily identified before the onset of retinal degeneration, making gene therapy a viable strategy to prevent their blindness.
Boye, S, Boye, SE, Chiodo, V, Dyka, F, Fofo, H, Hauswirth, WW, Lopes, VS, Louie, CM, Williams, DS   +8 more
core   +1 more source

Performance Evaluation of Red Light-Emitting Diodes for Therapeutic Photobiomodulation Device Design [PDF]

Iranian Journal of Medical Physics
Introduction: Photobiomodulation (PBM) therapy relies on precise control of optical parameters such as wavelength, irradiance, and beam geometry to achieve therapeutic efficacy.
Mohammad Reza Rashidian Vaziri, Majid HasanAbadi, Amirhossein Fathabadi, Mona Alikhanzadeh, Ameneh Sazgarnia   +4 more
doaj   +1 more source

Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation [PDF]

, 2005
OBJECTIVE: To describe the impairments of upper body and limbs, activity limitations and participation restrictions 6 and 12 months after operation for breast cancer and to examine the impact of impairments on activity limitations.
Kärki, Anne, Mälkiä, Esko, Selfe, James, Simonen, Riitta   +3 more
core   +1 more source

Low Level RF System of the LIGHT Proton Therapy Linac

, 2022
Talk presented at LLRF Workshop 2022 (LLRF2022, arXiv:2208.13680)
Guillen, Dario Soriano, De Michele, Giovanni, Benedetti, Stefano, Ivanisenko, Yevgeniy, Cerv, Matevz   +4 more
openaire   +2 more sources

Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco [PDF]

, 2014
The proposed clinical trial in Africa of VRC01, a potent broadly neutralizing antibody (bNAb) capable of neutralizing 91% of known HIV-1 isolates, raises concerns about testing a treatment which will be too expensive to be accessible by the most ...
EMEA, Montefiori D.C., Pabst M., Pegu A., WHO   +4 more
core   +1 more source